Uppsala universitet

   

 MOLECULAR MEDICINE


SNP Platform Home
Contact
Services
   DNA Sequencing
   SNP Genotyping
   SNP Bioinformatics
   SNP Methods &
   References

Quality system
   The quality manual
   Policy for genotyping
LIMS

Staff
Publications

Molecular Medicine Home
  

 
.
.
.

 STAFF UU

. ...   ...  

Welcome to the
SNP&SEQ Technology Platform

 

 

The SNP&SEQ Technology Platform performs genotyping of SNPs (single nucleotide polymorphisms) and sequencing as a service to academic researchers in Sweden and other countries. Our aim is to make SNP genotyping and sequencing of high quality, using the most modern technology available to researchers at the lowest possible cost. SNP genotyping has been offered since 2001 and from 2008 the platform also offers “next generation” DNA sequencing as a service to researchers.
SNP genotyping is offered for large-scale association or linkage studies, analysis of copy number variations and chromosomal rearrangements and DNA methylation levels. We can assist genotyping projects of varying size, from 1 SNP to >1,000,000 SNPs in hundreds or thousands of samples using four different genotyping systems to cover the needs of all projects.

  • Illumina iScan and BeadStation 500GX are used for genotyping of 384- >1,000,000 SNPs per sample using the GoldenGate and Infinium assays.
  • Illumina BeadXpress is used for 48-384 SNPs.
  • GenomeLab SNPstream is used for projects with 12-96 SNPs per sample.
  • Single-base extension with fluorescence polarization detection is used when only few SNPs are to be analysed per sample.

Sequencing of genomic DNA, targeted genomic regions, RNA (cDNA) and chromatin-immunoprecipitated DNA is performed using two Illumina Genome AnalyzerIIx systems.

The genotyping procedure at the SNP&SEQ Technology Platform is accredited by SWEDAC (the Swedish Board for Accreditation and Conformity Assessment) according to the international SS-EN ISO/IEC 17025:2005 quality standard. The sequencing procedure was included in the quality system during the fall 2009 and accreditation of the process will be sought in the fall of 2010.

Over 150 research projects, most of which have studied human complex diseases, have received service from the SNP&SEQ Technology Platform. Our services include bioinformatics-assisted custom SNP assay design or large fixed SNP panels followed by production scale genotyping and quality control of the results.

We have a staff of eight research engineers or laboratory technicians, four biocomputing engineers, one scientist and a laboratory manager. The staff of the SNP&SEQ Technology Platform is supported by Uppsala University, Uppsala University Hospital and the Swedish Research Council for Infrastructures.

Our computational infrastructure includes an “in-house” developed laboratory data management system. A relational MS SQL database is used for handling and storing information on samples, SNP-assays and produced genotypes, and for quality assessment of the genotype data. Next generation sequence data is handled by dedicated servers equipped with large capacity redundant storage. For delivery of the large amounts of data generated by next gen sequencing we are collaborating with UPPMAX, Uppsala University's resource of high-performance computers, in the UPPNEX project.
For information on how to get access to our services, please click HERE for contact information.
For information on how to get access to our services, please click HERE for contact information.
 


 

 

 

 NEWS!


Information about support from VR to the SNP&SEQ-platform:
Read more here


Recent publications:
The SNP platform has contributed to two large studies on glucose levels and type 2 diabetes that were published in Nature Genetics.
Read more here


 

 

 

 


 

 
 
 

 

©- 2001. Department of Medical Sciences
Akademiska sjukhuset, S-751 85 Uppsala
Telephone 018-611 00 00  Telefax 018-51 01 33

Webmaster | Contact
Telephone +46-18-611 00 00  
Telefax     +46-18-55 36 01